secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2022-11-29T23:59:59+00:00
Accession:  0001654954-22-015844
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Zivo Bioscience receives Nasdaq delisting notice for insufficient equity
------------------------------------------------------------------------

- Nasdaq notified Zivo on Nov 22, 2022 of non-compliance with minimum $2.5M stockholders' equity requirement.
- Equity fell below threshold as of Sept 30, 2022; alternative compliance standards also not met.
- Company has 45 days (until Jan 6, 2023) to submit a plan to regain compliance; possible 180-day extension.
- No immediate impact on trading; common stock (ZIVO) and warrants (ZIVOW) continue trading on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495422015844/0001654954-22-015844-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495422015844/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-015844

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer